Physician
Radiation Oncology
Dr. Andrew S. Kennedy, MD
|
|
Give Review
Andrew S. Kennedy, MD practices Radiation Oncology. He researched medicine at Loma Linda University School of Medicine. He has 1 awards "Meaningful Use Stage 1 Certification". Dr. Andrew S. Kennedy is also a published physician. He has 42 paper published. The most recent paper is: Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma.
Publications
- Safety and Efficacy of Radioembolization in Elderly (≥ 70 Years) and Younger Patients With Unresectable Liver-Dominant Colorectal Cancer.
- Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference.
- The limitations of theoretical dose modeling for yttrium-90 radioembolization.
- Radioembolization of hepatic tumors.
- Nonsurgical treatment for localized hepatocellular carcinoma.
- Integrating Radioembolization into the Treatment Paradigm for Metastatic Neuroendocrine Tumors in the Liver.
- A new catheter for tumor targeting with radioactive microspheres in representative hepatic artery systems. Part I: impact of catheter presence on local blood flow and ...
- A New Catheter for Tumor-Targeting With Radioactive Microspheres in Representative Hepatic Artery Systems-Part II: Solid Tumor-Targeting in a Patient-Inspired Hepatic ...
- Experimental microsphere targeting in a representative hepatic artery system.
- Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the ...
- Patient Selection and Activity Planning Guide for Selective Internal Radiotherapy with Yttrium-90 Resin Microspheres.
- Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis.
- Computer modeling of controlled microsphere release and targeting in a representative hepatic artery system.
- Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies.
- Computer modeling of yttrium-90-microsphere transport in the hepatic arterial tree to improve clinical outcomes.
- Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.
- Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution.
- 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.
- Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.
- Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer.
- Radioembolization with 90Y microspheres: angiographic and technical considerations.
- Resin 90Y microsphere activity measurements for liver brachytherapy.
- Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.
- Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma.
- Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications.
- Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers.
- Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma.
- Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors.
- Research reporting standards for radioembolization of hepatic malignancies.
- Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor t...
- Intra-arterial brachytherapy of hepatic malignancies: watch the flow.
- Cytotoxicity of docetaxel (Taxotere) used as a single agent and in combination with radiation in human gastric, cervical and pancreatic cancer cells.
- A first report of radioembolization for hepatic metastases from ocular melanoma.
- Survival of colorectal cancer cell lines treated with paclitaxel, radiation, and 5-FU: effect of TP53 or hMLH1 deficiency.
- Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays.
- Utility of radiation in the prevention of heterotopic ossification following repair of traumatic acetabular fracture.
- Comparison of three treatment options for single brain metastasis from lung cancer.
- Use of radiation therapy in posttransplant lymphoproliferative disorder (PTLD) after liver transplantation.
- Primary squamous cell carcinoma of the endometrium: a first report of adjuvant chemoradiation.
- High dose rate brachytherapy to prevent recurrent benign hyperplasia in lung transplant bronchi: theoretical and clinical considerations.
- Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma.
Schools
Loma Linda University
University Of North Carolina
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
University of North Carolina Hospitals -
Loma Linda University -
Loma Linda University School of Medicine
Drug Facts
| NPI NUMBER | 1467491019 | |
| NPPES Provider LastName | KENNEDY | |
| NPPES Provider FirstName | ANDREW | |
| NPPES Provider ZIPCode | 372031551 | |
| NPPES Provider State | TN | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 74.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 17.57 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1467491019 |
| Last Name Of The Provider | KENNEDY |
| First Name Of The Provider | ANDREW |
| View All |
Similar Doctors
|
Dr. James R. Gray Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul A. Rosenblatt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth M. Lloyd, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. My T. Nguyen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas A. Hunter, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Craig A. Collie, MD |
|
|
Dr. Steven L. Stroup, MD |
|
|
Dr. Kenneth J. Niermann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David E. Hunt, MD |
|
|
Dr. David R. Gius, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Albert Attia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Austin N. Kirschner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory R. Vlacich, MD |
|
|
Dr. Robert W. Mutter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey M. Friedman, MD |